Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

VIVS vs SSYS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SSYS Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

SSYS Overall Winner 6-Pillar Tally: VIVS 1 – 5 SSYS Matrix Metrics: VIVS 2 – 8 SSYS

As of Nov 19, 2026, Stratasys Inc (ISRAEL) (SSYS) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 39.0/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas SSYS carries 43.8/100 (HOLD) at $5.49 (45.8x Forward P/E, -10.3% operating margin).

  • Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile SSYS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About VIVS vs SSYS
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
TTM Revenue $112,000
Forward P/E N/M
Beta / 30D Vol 0.83β · 480% Vol
Unified Composite Score
39.0 / 100 SELL
Tech 5.0 Fund 47.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.1 · SMA20: $0.15 · SMA50: $0.18
SSYS NASDAQ Head-to-Head Winner
Stratasys Inc (ISRAEL)
Computer Peripheral Equipment, Nec
$5.49
-0.9% 1D
Market Cap $488.0M
TTM Revenue $553M
Forward P/E 45.8x
Beta / 30D Vol 2.07β · 63% Vol
Unified Composite Score
43.8 / 100 HOLD
Tech 35.0 Fund 44.0 Flow 56.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -8.0%), weak momentum, RSI 26
RSI-14: 26.3 · SMA20: $6.45 · SMA50: $7.27

6-Pillar Scorecard Institutional Category Breakdown (VIVS 1 – 5 SSYS)

Columns: Metric · VIVS · SSYS
1. Valuation Multiples SSYS
Forward P/E N/M 45.8x
Trailing P/E N/M 30.1x
PEG Ratio N/M 2.06x
EV / Revenue 9.6x 0.8x
2. Growth & Scale SSYS
Revenue Growth (YoY) -51.4% +4.1%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $112,000 $553M
Market Cap $2.4M $488.0M
3. Profitability & Quality SSYS
Gross Margin N/A 43.1%
Operating Margin -10117.0% -10.3%
Net Profit Margin 0.0% -12.6%
Return on Equity (ROE) -343.1% -8.4%
4. Balance Sheet & Cash Flow VIVS
Cash Generation (TTM) -$11M EBITDA -$25M
Cash Flow Margin N/A -4.6%
Net Cash / Leverage $1.4M Net Cash $67M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning SSYS
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile N/A (N/A) 68.2% (52nd %ile)
Put/Call OI Skew N/A 1.56x (Put-Skewed)
OBV Trend / Tech Phase ACCUMULATION · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat SSYS
OpEx & R&D Intensity N/A 53.4% of Rev ($295M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Computer Hardware Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: VIVS (2) vs SSYS (8)
Institutional Metric VIVS SSYS Criterion Row Edge
Market Capitalization
Scale
$2.4M $488.0M Larger Scale SSYS
Trailing P/E Ratio
Valuation
N/M 30.1x Lower Multiple SSYS
Forward P/E Ratio
Valuation
N/M 45.8x Lower Multiple SSYS
Revenue Growth (YoY)
Growth
-51.4% +4.1% Higher Growth SSYS
Operating Margin (TTM)
Profitability
-10117.0% -10.3% Higher Margin SSYS
Net Profit Margin
Profitability
0.0% -12.6% Higher Margin VIVS
Return on Equity (ROE)
Capital Efficiency
-343.1% -8.4% Higher ROE SSYS
52-Week Range Position
Momentum
5% ($0–$3) 1% ($5–$12) Stronger Trend VIVS
Beta / 30D Volatility
Risk Regime
0.83β · 480% Vol 2.07β · 63% Vol Lower Realized Risk SSYS
Unified Institutional Score
Composite Signal
39.0 / 100 (SELL) 43.8 / 100 (HOLD) Higher Composite SSYS
Trailing 12M Revenue (USD)
Operating Scale
$112,000 $553M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 43.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 9.6x EV/Rev 2.06x PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$11M EBITDA ($1.4M Net Cash) -$25M ($67M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon VIVS +85.58 pp
VIVS: +64.69% · SSYS: -20.89%
3M Horizon VIVS +32.43 pp
VIVS: +1.92% · SSYS: -30.51%
6M Horizon SSYS +42.61 pp
VIVS: -78.25% · SSYS: -35.64%
1Y Horizon SSYS +51.58 pp
VIVS: -86.99% · SSYS: -35.41%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period VIVS Revenue SSYS Revenue VIVS Op. Margin SSYS Op. Margin Margin Leader
FY2019 $0M $640M -882.4% -1.8% SSYS
FY2020 $0M $520M -977.9% -87.6% SSYS
FY2021 N/A $610M N/A -13.0% SSYS
FY2022 $0M $650M -765.3% -8.8% SSYS
FY2023 $0M $630M -4792.2% -14.0% SSYS
FY2024 $0M $570M -13840.4% -15.0% SSYS
FY2025 $0M $550M -8761.1% -13.2% SSYS
FY2026 $0M N/A -8768.7% N/A VIVS

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
VIVS BREAKDOWN
73d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact VIVS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SSYS BREAKDOWN
120d in phase · OBV DISTRIBUTION
Current IV 68.2%
IV Percentile 52nd %ile
Put/Call OI Skew 1.56x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact SSYS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
VIVS Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.4M market capitalization and -10117.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SSYS Moat Profile Cyclical / Execution-Driven Positioning
Computer Hardware Operator
Competes within the Computer Hardware value chain with $488.0M market capitalization and -10.3% operating margin.
OpEx & R&D Reinvestment 53.4% of Rev ($295M)
90D Engineering Disclosures 0 Published

Investor FAQ VIVS vs SSYS Key Questions & Quantitative Answers

As of Nov 19, 2026, Stratasys Inc (ISRAEL) (SSYS) is the stronger overall head-to-head candidate over VivoSim Labs, Inc. (VIVS) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). VIVS carries a Unified Composite Score of 39.0/100 (SELL) at $0.29 (N/M Forward P/E, -10117.0% operating margin), whereas SSYS carries 43.8/100 (HOLD) at $5.49 (45.8x Forward P/E, -10.3% operating margin). Technical & Structure Timing Caution: VIVS is currently in a Breakdown options structure phase (RSI 75.1); meanwhile SSYS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 26.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SSYS leads the Growth & Scale pillar: VIVS posts -51.4% YoY revenue growth and +0.0% YoY earnings growth on $112,000 TTM revenue (N/A gross margin, -10117.0% operating margin), compared with SSYS at +4.1% YoY revenue growth and +0.0% YoY earnings growth on $553M TTM revenue (43.1% gross margin, -10.3% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), VIVS cumulative revenue shifted N/A while SSYS shifted -14.1%. In operating R&D and SG&A reinvestment, VIVS deploys N/A (0 90-day corporate R&D disclosures) versus 53.4% of Rev ($295M) (0 disclosures) for SSYS.

SSYS screens cheaper on headline valuation multiples. VIVS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 9.6x EV/Revenue (unreported EBITDA margin), whereas SSYS trades at 45.8x Forward P/E, 30.1x Trailing P/E, 2.06x PEG, and 0.8x EV/Revenue (-4.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VIVS (-343.1% ROE) versus SSYS (-8.4% ROE) capital efficiency.

In options market volatility and institutional positioning, VIVS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (0.83β · 480% Vol realized risk). By comparison, SSYS carries 68.2% implied volatility (52nd %ile, Balanced (25th–60th %ile)), a 1.56x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.07β · 63% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.